Badal Justin, Ramasamy Ranjith, Hakky Tariq, Chandrashekar Aravind, Lipshultz Larry
Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
F1000Res. 2015 Jan 15;4:13. doi: 10.12688/f1000research.5743.1. eCollection 2015.
Erectile dysfunction has been explored as a condition secondary to elevated prolactin; however, the mechanisms by which elevated prolactin levels cause erectile dysfunction have not yet been clearly established. We here present a patient with a history of prolactinoma who suffered from persistent erectile dysfunction despite testosterone supplementation and pharmacological and surgical treatment for the prolactinoma. Patients who have had both prolactinemia and erectile dysfunction have been reported in the literature, but we find no report of a patient with persistent erectile dysfunction in the setting of testosterone supplementation and persistent hyperprolactinemia refractory to treatment. This case provides evidence supporting the idea that suppression of erectile function occurs in both the central and peripheral nervous systems independent of the hypothalamic-pituitary-gonadal axis.
勃起功能障碍已被作为高催乳素血症继发的一种病症进行研究;然而,高催乳素水平导致勃起功能障碍的机制尚未明确确立。我们在此报告一名患有泌乳素瘤病史的患者,尽管补充了睾酮并对泌乳素瘤进行了药物和手术治疗,但仍患有持续性勃起功能障碍。文献中已报道了同时患有高催乳素血症和勃起功能障碍的患者,但我们未发现有关于在补充睾酮及存在持续性高催乳素血症且治疗无效情况下出现持续性勃起功能障碍患者的报告。该病例提供了证据支持这样一种观点,即勃起功能抑制发生在中枢和外周神经系统,且独立于下丘脑 - 垂体 - 性腺轴。